BTF Northwest Women's Cancer Conference

BTF Northwest Women's Cancer Conference is organized by Binaytara Foundation (BTF) and will be held on Sep 17, 2022 at DoubleTree by Hilton Hotel Portland, Portland, Oregon, United States of America.

Overview:
The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Conference Highlights:
• Audience response system
• Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
• Opportunities to network with colleagues and interact with faculties
• Program topics are clinically relevant and can immediately be applied to clinical practice.

Learning Objectives:
Upon successful completion of this educational activity, participants will be able to:
• Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of women’s cancers
• Review frequent molecular abnormalities in women’s cancers, and appropriate timing of testing to detect these abnormalities.
• Integrate emerging evidence in precision oncology into treatment paradigms for the treatment of women’s cancer.
• Compare and contrast the safety and efficacy profiles of novel therapeutic strategies in the management of women’s cancers.